Orchid Pharma reports consolidated net loss of Rs 12.61 crore in the December 2025 quarter
(12 Feb 2026)

Back
Net loss of Orchid Pharma reported to Rs 12.61 crore in the quarter ended December 2025 as against net profit of Rs 20.78 crore during the previous quarter ended December 2024. Sales declined 4.63% to Rs 207.27 crore in the quarter ended December 2025 as against Rs 217.34 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales207.27217.34 -5
OPM %0.7512.13 -
PBDT3.9931.06 -87
PBT-5.0422.45 PL
NP-12.6120.78 PL

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew